Skip to main content

Table 2 Baseline chemical markers (with cut-offs) of the study population (n=1,096)

From: Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study

Factor Strata n %
Bilirubin Normal 624 56.9%
  High (>1.2 mg/dL) 31 2.8%
  Unknown 441 40.2%
Total Cholesterol Normal 478 43.6%
  High (≥200 mg/dL) 107 9.8%
  Unknown 511 46.6%
Hemoglobin Low (<12 g/dL) 158 14.4%
  Normal 593 54.1%
  Unknown 345 31.5%
GammaGT Normal 453 41.3%
  High (>60 IU/L) 145 13.2%
  Unknown 498 45.4%
Glucose Normal 674 61.5%
  High (>110 mg/dl) 34 3.1%
  Diabetes (>126 mg/dL) 22 2.0%
  Unknown 366 33.4%
GPT Normal 561 51.2%
  High (>40 IU/L) 224 20.4%
  Unknown 311 28.4%
HDL Low (<40 mg/dL) 217 19.8%
  Normal 121 11.0%
  Unknown 758 69.2%
LDL Normal 306 27.9%
  High (≥130 mg/dL) 12 1.1%
  Unknown 778 71.0%
Tryglicerides Normal 383 34.9%
  high (≥150 mg/dL) 178 16.2%
  Unknown 535 48.8%
MDRD Low (<60 mg/dL/1.73m2) 20 1.8%
  Normal 694 63.3%
  Unknown 382 34.9%